XYLASED 20 DIN 02540894
Status: Marketed
Holder: MODERN VETERINARY THERAPEUTICS LLC
Molecule: XYLAZINE (XYLAZINE HYDROCHLORIDE)
Health Canada record
| Active ingredient(s) | XYLAZINE (XYLAZINE HYDROCHLORIDE) 20 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Subcutaneous; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 28-Jun-2024 |
| Current status date | 28-Jun-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Modern Veterinary Therapeutics Inc — licence 3-002686, currently licensed, last inspection rating I (2026-07-08).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing XYLAZINE (XYLAZINE HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02243680 | CHANAZINE 100MG INJECTION | CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED | Liquid | XYLAZINE (XYLAZINE HYDROCHLORIDE) 100 MG | Approved |
| 02450240 | NERFASIN 100 | DECHRA REGULATORY BV | Solution | XYLAZINE (XYLAZINE HYDROCHLORIDE) 100 MG | Marketed |
| 02169606 | ROMPUN | ELANCO CANADA LIMITED | Solution | XYLAZINE (XYLAZINE HYDROCHLORIDE) 100 MG | Marketed |
| 02169592 | ROMPUN | ELANCO CANADA LIMITED | Solution | XYLAZINE (XYLAZINE HYDROCHLORIDE) 20 MG | Marketed |
| 00805475 | XYLAMAX INJECTION 100MG/ML | BIMEDA-MTC ANIMAL HEALTH INC | Liquid | XYLAZINE (XYLAZINE HYDROCHLORIDE) 100 MG | Marketed |
| 02545063 | XYLASED 100 | MODERN VETERINARY THERAPEUTICS LLC | Solution | XYLAZINE (XYLAZINE HYDROCHLORIDE) 100 MG | Marketed |
| 00682233 | ANASED | AKORN ANIMAL HEALTH INC | Solution | XYLAZINE (XYLAZINE HYDROCHLORIDE) 100 MG | Cancelled (Unreturned Annual) |
| 02094908 | ANASED | AKORN ANIMAL HEALTH INC | Solution | XYLAZINE (XYLAZINE HYDROCHLORIDE) 20 MG | Cancelled (Unreturned Annual) |
| 02444089 | NERFASIN 20 | DECHRA REGULATORY BV | Solution | XYLAZINE (XYLAZINE HYDROCHLORIDE) 20 MG | Dormant |
| 02239094 | NV-ANASED INJECTABLE 100MG/ML | NOVOPHARM LIMITED | Solution | XYLAZINE (XYLAZINE HYDROCHLORIDE) 100 MG | Cancelled Post Market |
| 02239093 | NV-ANASED INJECTABLE 20MG/ML | NOVOPHARM LIMITED | Liquid | XYLAZINE (XYLAZINE HYDROCHLORIDE) 20 MG | Cancelled Post Market |
| 02089890 | ROMPUN 100MG/ML INJECTABLE | MILES CANADA INC. - AGRIC., DIVISION OF ANIMAL HEALTH | Liquid | XYLAZINE (XYLAZINE HYDROCHLORIDE) 100 MG | Cancelled Post Market |
| 02089904 | ROMPUN 20MG/ML INJECTABLE | MILES CANADA INC. - AGRIC., DIVISION OF ANIMAL HEALTH | Liquid | XYLAZINE (XYLAZINE HYDROCHLORIDE) 20 MG | Cancelled Post Market |
| 02237528 | XYLAZINE HCL INJECTION | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Liquid | XYLAZINE (XYLAZINE HYDROCHLORIDE) 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 32365 | 2023-12-18 | Supplement to an Abbreviated New Drug Submission (SANDS) | Administrative - Change in brand name |
| 31491 | 2023-08-25 | Abbreviated New Drug Submission (ANDS) |